MedTrace Logo

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease

NCT01538212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2016-04-18

No results posted yet for this study

Summary

This evaluation of the efficacy and safety of AXONA will be a chart review carried out at 16 practices in which AXONA has been prescribed for the treatment of patients with mild-to-moderate AD. Efficacy of AXONA will be assessed by comparison of patient status before and after initiation of treatment.

Conditions

Sponsors & Collaborators

  • Cerecin

    lead INDUSTRY

Principal Investigators

  • Samuel T Henderson, PhD · Cerecin

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538212 on ClinicalTrials.gov